SCHEMBL21777249

SCHEMBL21777249

CC(C)(C)OC(=O)N1CC[C@H](OCCCCBr)C1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 2/20 0.44
WDR77 Q9BQA1 2/20 0.44
GPR119 Q8TDV5 5/20 0.41
PIK3CD O00329 1/20 0.41
HPGD P15428 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
USP30 Q70CQ3 1/20 0.39
RECQL P46063 1/20 0.39
EPHX1 P07099 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
NR1H2 P55055 1/20 0.39
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21767695 1.00 PRMT5 (0.44) PRMT5WDR77GPR119PIK3CDHPGD
SCHEMBL21767696 1.00 PRMT5 (0.44) PRMT5WDR77GPR119PIK3CDHPGD
SCHEMBL5039027 0.92 HPGD (0.46) PRMT5WDR77GPR119HPGDRECQL
SCHEMBL6132494 0.91 GPR119 (0.47) PRMT5WDR77GPR119HPGDRECQL
SCHEMBL7685759 0.91 GPR119 (0.47) PRMT5WDR77GPR119HPGDRECQL
SCHEMBL30750595 0.91 GPR119 (0.47) PRMT5WDR77GPR119HPGDRECQL
SCHEMBL22907261 0.89 NR1H2 (0.46) PRMT5WDR77GPR119HPGDMEN1
SCHEMBL21997478 0.88 HPGD (0.47) PRMT5WDR77GPR119HPGDMAPT
SCHEMBL28684525 0.86 PRMT5 (0.46) PRMT5WDR77GPR119PIK3CDHPGD
SCHEMBL13107602 0.86 PRMT5 (0.46) PRMT5WDR77GPR119PIK3CDHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3843727-A1 INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN Morphic Therapeutic, Inc. (US) 2021-07-07 EP disclosed
EP-3843728-A1 INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN Morphic Therapeutic, Inc. (US) 2021-07-07 EP disclosed
WO-2020047239-A1 INHIBITING αV β6 INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2020-03-05 WO disclosed
WO-2020047207-A1 INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN MORPHIC THERAPEUTICS, INC. (US) 2020-03-05 WO disclosed
WO-2020047208-A1 INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2020-03-05 WO disclosed